🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.2750
-0.0143 (-4.94%)
At close: Nov 19, 2026, 4:00 PM EST
0.2870
+0.0120 (4.36%)
After-hours: Nov 19, 2026, 7:30 PM EST

Mereo BioPharma Group Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
26.140.9969.857.4268.18126.91
Short-Term Investments
-----0.77
Cash & Short-Term Investments
26.140.9969.857.4268.18127.68
Cash Growth
-46.41%-41.27%21.56%-15.78%-46.60%298.48%
Other Receivables
0.311.983.253.732.312.46
Receivables
0.311.983.253.732.312.46
Prepaid Expenses
2.270.380.270.973.783.79
Other Current Assets
-1.661.441.640.920.55
Total Current Assets
28.6745.0274.7663.7675.2134.49
Property, Plant & Equipment
0.780.380.981.652.223.43
Other Intangible Assets
0.130.520.641.09-33.26
Total Assets
29.5845.9276.3966.577.41171.18

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
11.432.682.353.493.09
Accrued Expenses
3.022.354.575.755.645.44
Current Portion of Long-Term Debt
--5.54-13.33-
Current Portion of Leases
0.580.20.710.650.560.84
Current Income Taxes Payable
-----2.06
Other Current Liabilities
0.90.330.360.741.365.55
Total Current Liabilities
5.494.313.859.4924.3816.98
Long-Term Debt
---4.39-19.48
Long-Term Leases
--0.190.911.482.38
Other Long-Term Liabilities
0.380.71.391.180.1613.18
Total Liabilities
5.87515.4215.9626.0152.02

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
3.153.143.062.782.482.38
Additional Paid-In Capital
553.24549.62539.64486.11476.52335.08
Retained Earnings
-520.41-501.02-462.88-419.63-404.58-402.11
Treasury Stock
----1.23-1.34-
Comprehensive Income & Other
-12.27-10.82-18.85-17.49-21.69183.82
Shareholders' Equity
23.7140.9260.9750.5451.4119.16
Total Liabilities & Equity
29.5845.9276.3966.577.41171.18

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
0.580.26.435.9515.3722.69
Net Cash (Debt)
25.5240.7963.3751.4752.81104.99
Net Cash Growth
-47.16%-35.63%23.13%-2.54%-49.70%1289.80%
Net Cash Per Share
0.160.260.430.390.440.95
Filing Date Shares Outstanding
159.7159.62159140.01124.74116.73
Total Common Shares Outstanding
159.69159.13155.15140124.74116.73
Working Capital
23.1840.7260.9254.2750.82117.51
Book Value Per Share
0.150.260.390.360.411.02
Tangible Book Value
23.5840.460.3349.4551.485.9
Tangible Book Value Per Share
0.150.250.390.350.410.74
Machinery
-0.460.490.50.610.48
Leasehold Improvements
-0.760.710.710.680.75
SEC Filings: 10-K · 10-Q